RVL Pharmaceuticals plc
RVLPQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -68.27M | -56.48M | -51.69M | -53.10M | -56.51M |
| Total Depreciation and Amortization | 382.00K | 379.00K | 375.00K | 382.00K | 441.00K |
| Total Amortization of Deferred Charges | 1.13M | 2.10M | 3.06M | 4.00M | 4.41M |
| Total Other Non-Cash Items | 24.34M | 5.66M | 6.06M | 780.00K | 1.04M |
| Change in Net Operating Assets | -1.99M | 18.00M | 4.39M | 2.16M | -995.00K |
| Cash from Operations | -44.41M | -30.35M | -37.81M | -45.77M | -51.60M |
| Capital Expenditure | -3.08M | -2.03M | -752.00K | -177.00K | -411.00K |
| Sale of Property, Plant, and Equipment | 950.00K | 920.00K | 878.00K | 400.00K | 159.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 110.85M |
| Cash from Investing | -2.13M | -1.11M | 126.00K | 223.00K | 110.59M |
| Total Debt Issued | 20.81M | 20.81M | 20.81M | 74.20M | 55.11M |
| Total Debt Repaid | -6.23M | -6.69M | -2.71M | -33.33M | -218.79M |
| Issuance of Common Stock | 23.82M | 23.82M | 23.85M | 56.22M | 32.63M |
| Repurchase of Common Stock | -122.00K | -179.00K | -164.00K | -150.00K | -307.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38.28M | 37.76M | 41.78M | 96.95M | -131.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.25M | 6.30M | 4.10M | 51.40M | -72.36M |